|

Intervention 2: Semaglutide Clinical Trials

1 actively recruiting trial across 1 location

Top Sponsors

  • University of Texas Southwestern Medical Center1

Indications

  • Mild Autonomous Cortisol Excess1
  • Subclinical Cushing's1
  • Mild Autonomous Cortisol Secretion (MACS)1
  • Autonomous Cortisol Secretion (ACS)1
  • Weight Loss1

Dallas, Texas1 trial

IMPACT-MACS: Adrenalectomy vs Semaglutide for Metabolic Outcomes in Mild Autonomous Cortisol Secretion

University of Texas Southwestern Medical Center

N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.